Search
Returning search results with filters:
Remove filter for
Audience: General public
Remove filter for
Category: Health products
Remove filter for
Type: Information update
Clear all
Search filters
Type
Audience
Category
Issue
Last updated
Displaying 16 - 30 of 37 items.
Multiple Losartan-containing drugs voluntarily recalled because of potential for nitrosamine impurity
AlertInformation update | 2019-03-09
Health Canada recommends that children and youth not use cough and cold products that contain opioids
AlertInformation update | 2019-02-18
Health Canada will be updating its safety review of breast implants
AlertInformation update | 2019-02-12
Important new safety information regarding the use of hydrochlorothiazide and the risk of non-melanoma skin cancer
AlertInformation update | 2019-01-31
Health Canada releases test results of certain sartan drugs
AlertInformation update | 2018-12-20
Cannabis and Alcohol Use During the Holidays
AlertInformation update | 2018-12-17
Information Update - Mylan-Valsartan medications voluntarily recalled as a precaution due to an impurity
AlertInformation update | 2018-11-28
Summary Safety Review: Health Canada concludes that there are no new safety concerns with sunscreen products
AlertInformation update | 2018-11-26
Health Canada reminds Canadians of the risks of decorative contact lenses
AlertInformation update | 2018-10-12
Health Canada reminds Canadians to consult a health professional before using high-concentration hydroquinone products
AlertInformation update | 2018-09-25
Health Canada updates Canadians on estimates of health risks for recalled valsartan drugs containing NDMA
AlertInformation update | 2018-09-10
Drug and Alcohol Use During Orientation Week
AlertInformation update | 2018-08-20
Expansion of recall of valsartan drugs to include additional lots, as a precaution
AlertInformation update | 2018-08-18
Health Canada updates Canadians on shortage situation involving EpiPen (0.3 mg) auto-injectors
AlertInformation update | 2018-07-30